TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.35, sa.2, ss.89-96, 2010 (SCI-Expanded)
Introduction: We earlier reported on anti-mycobacterial and monoamine oxidase (MAO) inhibitory activity of 3, 5-diaryl-2-pyrazoline 1-carbothioamides with structural similarities to Mycobactin. The same thirty two compounds have been evaluated for Acetylcholinesterase (AChE) inhibitory activity in a search for dual inhibitors against MAO-B/AChE which may have potential therapeutic utility in Alzheimer Disease (AD).